Non-alcoholic fatty liver disease in a patient with maturity onset diabetes in the young.
作者信息
Masih Izhaq, McIlwaine Werner
机构信息
Ulster Hospital, Medicine, 41 Falcon Avenue, Newtownards, BT23 4 GE, UK.
出版信息
BMJ Case Rep. 2009;2009. doi: 10.1136/bcr.07.2008.0436. Epub 2009 Apr 28.
Abstract
We present the case of a 34-year-old man who was first seen in our clinic in 2003. His α-glutamyl transferase (GGT) was raised but the rest of the liver function tests (LFTs) and liver screen were normal. He was diagnosed with maturity onset diabetes of the young (MODY) when he was 21 years old. Abdominal ultrasound showed fatty liver disease. Liver biopsy in 2006 showed non-alcoholic fatty liver disease (NAFLD). This combination has rarely been described in the medical literature. Metformin and gliclizide was started and weight reduction advised. Despite this there is no change in his LFTs, and in 2008, his GGT concentration was even higher. This condition is challenging because of the limited treatment options. Globally, NAFLD is rising and complications such as liver cirrhosis can be seen commonly. NAFLD in a patient with MODY needs thorough attention.
摘要
相似文献
1
Non-alcoholic fatty liver disease in a patient with maturity onset diabetes in the young.
BMJ Case Rep. 2009;2009. doi: 10.1136/bcr.07.2008.0436. Epub 2009 Apr 28.
2
Diagnostic value of alcoholic liver disease (ALD)/nonalcoholic fatty liver disease (NAFLD) index combined with γ-glutamyl transferase in differentiating ALD and NAFLD.酒精性肝病（ALD）/非酒精性脂肪性肝病（NAFLD）指数联合γ-谷氨酰转移酶在鉴别ALD和NAFLD中的诊断价值。
Korean J Intern Med. 2016 May;31(3):479-87. doi: 10.3904/kjim.2015.253. Epub 2016 Mar 30.
3
Profile of liver enzymes in non-alcoholic fatty liver disease in patients with impaired glucose tolerance and newly detected untreated type 2 diabetes.糖耐量受损和新诊断未治疗的2型糖尿病患者非酒精性脂肪性肝病中的肝酶谱
Indian J Endocrinol Metab. 2015 Sep-Oct;19(5):597-601. doi: 10.4103/2230-8210.163172.
4
Onset of Ulcerative Colitis in a Patient with Nonalcoholic Fatty Liver Disease (NAFLD): Dramatic Effect of Plant-based Diet for NAFLD.非酒精性脂肪性肝病（NAFLD）患者溃疡性结肠炎的发作：植物性饮食对 NAFLD 的显著疗效。
Inflamm Bowel Dis. 2019 Oct 18;25(11):e146-e147. doi: 10.1093/ibd/izz208.
5
Diagnosis of non-alcoholic fatty liver disease (NAFLD).非酒精性脂肪性肝病（NAFLD）的诊断
Diabetologia. 2016 Jun;59(6):1104-11. doi: 10.1007/s00125-016-3944-1. Epub 2016 Apr 18.
6
Gamma glutamyl transferase is an independent determinant for the association of insulin resistance with nonalcoholic fatty liver disease in Bangladeshi adults: Association of GGT and HOMA-IR with NAFLD.γ-谷氨酰转移酶是孟加拉国成年人胰岛素抵抗与非酒精性脂肪性肝病关联的独立决定因素：γ-谷氨酰转移酶和胰岛素抵抗指数与非酒精性脂肪性肝病的关联
Diabetes Metab Syndr. 2016 Jan-Mar;10(1 Suppl 1):S25-9. doi: 10.1016/j.dsx.2015.09.005. Epub 2015 Oct 9.
7
Obesity and metabolic syndrome as risk factors for the development of non-alcoholic fatty liver disease as diagnosed by ultrasound.肥胖和代谢综合征作为通过超声诊断的非酒精性脂肪性肝病发生的风险因素。
Vojnosanit Pregl. 2016 Oct;73(10):910-20. doi: 10.2298/VSP150514093P.
8
Factors predicting non-alcoholic steatohepatitis (NASH) and advanced fibrosis in patients with non-alcoholic fatty liver disease (NAFLD).预测非酒精性脂肪性肝病（NAFLD）患者非酒精性脂肪性肝炎（NASH）和肝纤维化进展的因素。
Trop Doct. 2018 Apr;48(2):107-112. doi: 10.1177/0049475517742261. Epub 2017 Nov 16.
9
Type 2 Diabetes Mellitus-Induced Hyperglycemia in Patients with NAFLD and Normal LFTs: Relationship to Lipid Profile, Oxidative Stress and Pro-Inflammatory Cytokines.非酒精性脂肪性肝病且肝功能正常患者的2型糖尿病诱发的高血糖症：与血脂谱、氧化应激和促炎细胞因子的关系
Sci Pharm. 2011 Jul-Sep;79(3):623-34. doi: 10.3797/scipharm.1104-21. Epub 2011 May 29.
10
Effect of silymarin plus vitamin E in patients with non-alcoholic fatty liver disease. A randomized clinical pilot study.水飞蓟素联合维生素E对非酒精性脂肪性肝病患者的影响。一项随机临床试验研究。
Eur Rev Med Pharmacol Sci. 2015 Aug;19(16):3118-24.
本文引用的文献
1
Comparative review of diets for the metabolic syndrome: implications for nonalcoholic fatty liver disease.代谢综合征饮食的比较综述：对非酒精性脂肪性肝病的影响
Am J Clin Nutr. 2007 Aug;86(2):285-300. doi: 10.1093/ajcn/86.2.285.
2
Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients.2型糖尿病患者中非酒精性脂肪性肝病的患病率及其与心血管疾病的关联。
Diabetes Care. 2007 May;30(5):1212-8. doi: 10.2337/dc06-2247. Epub 2007 Feb 2.
3
A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis.一项关于吡格列酮治疗非酒精性脂肪性肝炎患者的安慰剂对照试验。
N Engl J Med. 2006 Nov 30;355(22):2297-307. doi: 10.1056/NEJMoa060326.
4
Genetic basis of maturity-onset diabetes of the young.青年发病型糖尿病的遗传基础。
Endocrinol Metab Clin North Am. 2006 Jun;35(2):371-84, x. doi: 10.1016/j.ecl.2006.02.009.
5
Type 2 diabetes in children is frequently associated with elevated alanine aminotransferase.
J Pediatr Gastroenterol Nutr. 2005 Jul;41(1):94-8. doi: 10.1097/01.mpg.0000164698.03164.e5.
6
Therapeutic strategies in nonalcoholic fatty liver disorders.非酒精性脂肪性肝病的治疗策略
Expert Opin Emerg Drugs. 2005 May;10(2):237-9. doi: 10.1517/14728214.10.2.237.
7
Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma.糖尿病会增加患慢性肝病和肝细胞癌的风险。
Gastroenterology. 2004 Feb;126(2):460-8. doi: 10.1053/j.gastro.2003.10.065.
8
[Maturity-onset diabetes of the young--MODY. Molecular-genetic, pathophysiological and clinical characteristics].[青年发病的成年型糖尿病——MODY。分子遗传学、病理生理学及临床特征]
Ugeskr Laeger. 2002 Apr 8;164(15):2017-22.
9
Prevalence of abnormal serum aminotransferase values in overweight and obese adolescents.超重和肥胖青少年血清转氨酶值异常的患病率
J Pediatr. 2000 Jun;136(6):727-33.
10
Liver transplantation for jejunoileal bypass-associated cirrhosis: allograft histology in the setting of an intact bypassed limb.
Liver Transpl Surg. 1997 Jan;3(1):23-7.
Zotero 插件